PPARGC1A and chronic obstructive pulmonary disease: Furthermore, the levels of p‐AMPK, Sirt1, PGC‐1‐α, and TFAM were elevated in the lung tissues of rhCC16‐treated COPD mice and decreased in those of mice with COPD (Figure 6B,C).